Antisense inhibition of MEKK2 expression
US6287860A · kind A · utility
103Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2000 |
| Grant date | Sep 11, 2001 |
| Priority date | — |
| Expiry date | Jan 20, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of MEKK2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding MEKK2. Methods of using these compounds for modulation of MEKK2 expression and for treatment of diseases associated with expression of MEKK2 are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.